These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21504243)

  • 1. Is there a role for pharmacoeconomics in developing countries?
    Harper JR
    Pharmacoeconomics; 2011 May; 29(5):435-6; author reply 436-7. PubMed ID: 21504243
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for pharmacoeconomics in developing countries?
    Velasco RP; Teerawattananon Y
    Pharmacoeconomics; 2011 May; 29(5):433-5; author reply 436-7. PubMed ID: 21504242
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis: developing nations left behind.
    Singer ME
    Pharmacoeconomics; 2008; 26(5):359-61. PubMed ID: 18429653
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacoeconomics: state of the art in 1997.
    Schulman KA; Linas BP
    Annu Rev Public Health; 1997; 18():529-48. PubMed ID: 9143730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomics comes of age?
    Walley T; Breckenridge A
    Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NICE to advise firms on how to speed up NHS adoption of their drugs.
    Hawkes N
    BMJ; 2015 May; 350():h2813. PubMed ID: 26002040
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomics and managed care: methodologic and policy issues.
    Luce BR
    Med Decis Making; 1998; 18(2 Suppl):S4-11. PubMed ID: 9566461
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a role for pharmacoeconomics in developing countries?
    Shafie AA; Hassali MA
    Pharmacoeconomics; 2011 Jan; 29(1):83-4; author reply 84-6. PubMed ID: 21142279
    [No Abstract]   [Full Text] [Related]  

  • 11. Is there a role for pharmacoeconomics in developing countries?
    Babar ZU; Scahill S
    Pharmacoeconomics; 2010; 28(12):1069-74. PubMed ID: 21080732
    [No Abstract]   [Full Text] [Related]  

  • 12. Advanced purchase commitments for a malaria vaccine.
    Natl Bur Econ Res Bull Aging Health; 2005; (12):1-2. PubMed ID: 16175672
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacoeconomics and health policy. Current applications and prospects for the future.
    Greenberg PE; Arcelus A; Birnbaum HG; Cremieux PY; LeLorier J; Ouellette P; Slavin MB
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):425-32. PubMed ID: 10662390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assessment of health economic evaluation.
    Chaikledkaew U; Kittrongsiri K
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S113-8. PubMed ID: 24964708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an equitable health policy in an era of limited resources.
    Kitzhaber J
    Semin Anesth; 1991 Sep; 10(3):211-9. PubMed ID: 11651361
    [No Abstract]   [Full Text] [Related]  

  • 16. Globalization and pharmacy: a view from the developing world.
    Matowe L; Katerere DR
    Ann Pharmacother; 2002 May; 36(5):936-8. PubMed ID: 12014352
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union.
    Beletsi A; Koutrafouri V; Karampli E; Pavi E
    Value Health Reg Issues; 2018 Sep; 16():81-91. PubMed ID: 30316029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource allocation decisions in low-income rural households.
    Franklin DL; Harrell MW
    Food Policy; 1985 May; 10(2):100-8. PubMed ID: 12340157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Globalisation, health policy and the exercise of power--a second opinion on Gilbert and Gilbert (2004).
    Thomas S; Thiede M
    Health Policy; 2005 Jun; 72(3):261-4. PubMed ID: 15862634
    [No Abstract]   [Full Text] [Related]  

  • 20. [Economic evaluations more and more important in healthcare decision making. Costs must be balanced against benefits also in studies on health economics].
    Lundkvist J
    Lakartidningen; 2006 Nov 15-21; 103(46):3624-7. PubMed ID: 17153872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.